Immunohistochemical analysis of transcription intermediary factor-1? (TIF1-?) antibodies expression in the skin of adult anti-TIF1-? positive dermatomyositis patients
Recruiting
- Conditions
- M33.1Other dermatomyositis
- Registration Number
- DRKS00025768
- Lead Sponsor
- Johannes Wesling Klinikum Universitätsklinik für Dermatologie, Venerologie, Allergologie und PhlebologieUK der Ruhr-Universität Bochum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Diagnosed adult dermatomyositis
- Serological evidence of TIF1-gamma available
- Presence of an archived skin biopsy
- Availability of patient data (clinical and serological)
- Adult male and female patients
Exclusion Criteria
No qualitative skin sample material available
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Distribution of immunohistochemically measured expression (ordinal scale) of TIF1-? in skin samples from patients with TIF1-gamma positive adult dermatomyositis
- Secondary Outcome Measures
Name Time Method 1. Association between phenotype (clinical and serological patient characteristics) and TIF1-? expression in the skin. 2. Proportion of associated malignancies in patients with TIF1-? positive adult dermatomyositis. 3. Proportion of patients with TIF1-? expression in the skin in control group (patients with TIF1-? negative adult dermatomyositis)<br>